Sales 2024 * | 2.75B 2.94B 4.04B | Sales 2025 * | 2.75B 2.94B 4.04B | Capitalization | 20.77B 22.23B 30.55B |
---|---|---|---|---|---|
Net income 2024 * | -419M -448M -616M | Net income 2025 * | -548M -586M -806M | EV / Sales 2024 * | 2.95 x |
Net cash position 2024 * | 12.67B 13.56B 18.64B | Net cash position 2025 * | 12.02B 12.86B 17.68B | EV / Sales 2025 * | 3.18 x |
P/E ratio 2024 * |
-47.6
x | P/E ratio 2025 * |
-37.7
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.48% |
Latest transcript on BioNTech SE
Managers | Title | Age | Since |
---|---|---|---|
Ugur Sahin
CEO | Chief Executive Officer | 58 | 08-06-01 |
Özlem Türeci
FOU | Founder | 57 | 08-06-01 |
Jens Holstein
DFI | Director of Finance/CFO | 60 | 21-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rudolf Staudigl
BRD | Director/Board Member | 70 | 21-12-31 |
Director/Board Member | 67 | 08-06-01 | |
Helmut Jeggle
CHM | Chairman | 53 | 08-06-01 |
1st Jan change | Capi. | |
---|---|---|
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B | |
+106.26% | 10.31B |